AA
DPLO

AlphaMark Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

AlphaMark Advisors’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-48,616
Closed -$654K – 529
2018
Q4 		$654K Hold
48,616
– – 0.31% 58
2018
Q3 		$944K Buy
48,616
+7,570
+18% +$161K 0.38% 52
2018
Q2 		$1.05M Hold
41,046
– – 0.42% 53
2018
Q1 		$827K Hold
41,046
– – 0.35% 62
2017
Q4 		$824K Buy
+41,046
New +$807K 0.32% 65

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AlphaMark Advisors's DPLO Position: Q1 2019 in Review

AlphaMark Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2019, closing a stake of 48,616 shares — an estimated $654K sold.

AlphaMark Advisors first reported a position in DPLO in Q4 2017 and held it in 5 quarters. The position peaked at $1.05M in Q2 2018. 150 funds tracked by Wall St. Rank hold DPLO as of Q1 2019.

  • AlphaMark Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2019 after selling out during the quarter.
  • AlphaMark Advisors sold 48,616 DIPLOMAT PHARMACY, INC. shares in Q1 2019, an estimated $654K.
  • AlphaMark Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2017 and held it in 5 quarters.
  • AlphaMark Advisors's DIPLOMAT PHARMACY, INC. position peaked at $1.05M in Q2 2018.
  • 150 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2019.

Based on AlphaMark Advisors's 13F filing for Q1 2019, filed 9 May 2019.